The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

Yazar: Larsen, Anna Thorsø, Gydesen, Sofie, Sonne, Nina, Karsdal, Morten Asser, Henriksen, Kim
Yayımlandı BMC Endocr Disord (2021)

A novel dual amylin and calcitonin receptor agonist, KBP‐089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference

Yazar: Gydesen, Sofie, Hjuler, Sara Toftegaard, Freving, Zenia, Andreassen, Kim Vietz, Sonne, Nina, Hellgren, Lars I, Karsdal, Morten Asser, Henriksen, Kim
Yayımlandı Br J Pharmacol (2017)